| answer text |
<p>The Department funds research via the National Institute for Health Research (NIHR).</p><p>
</p><p>The types of biomedical and health related research that are funded by NIHR
and other funders can be classified using the Health Research Classification System
(HRCS). Whilst HRCS does not have a category that is specifically ‘new medicines’,
HRCS codes 5.1 and 6.1 relate to the development and evaluation of pharmaceutical
treatments and therapeutic interventions and can be used to classify NIHR Programme
Spend. It is possible that these codes may include some evaluation of existing medicines.</p><p>
</p><p>In addition, the NIHR Clinical Research Network (CRN) undertakes research which
supports clinical trials into pharmaceutical treatments and therapeutic interventions.
CRN funding data can be calculated based on the number of recruiting 'Clinical Trial
of an Investigational Medicinal Product (CTIMP)' studies within the CRN Portfolio.</p><p>
</p><p>NIHR programme research spend classified under HRCS codes 5.1 and 6.1 and CRN
CTIMP spend over the last three years where complete data is available is shown in
the following table:</p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2014/15</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td></tr><tr><td><p>NIHR
Programme Spend</p></td><td><p>£34,204,157.67</p></td><td><p>£36,655,975.32</p></td><td><p>£39,011,490.62</p></td></tr><tr><td><p>CRN
spend</p></td><td><p>£76,600,272.00</p></td><td><p>£77,676,259.00</p></td><td><p>£77,036,034.00</p></td></tr><tr><td><p>
</p></td><td><p>£110,804,429.67</p></td><td><p>£114,332,234.32</p></td><td><p>£116,047,524.62</p></td></tr></tbody></table><p><br>Research
which may also contribute to the development and evaluation of pharmaceutical treatments
and therapeutic interventions carried out across NIHR Infrastructure is not coded
by the HRCS scheme so cannot be wholly attributed to individual research topics.</p>
|
|
